Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022

Saved in:
Bibliographic Details
Published in:MMWR. Morbidity and mortality weekly report Vol. 71; no. 9; pp. 352 - 358
Main Authors: Klein, Nicola P, Stockwell, Melissa S, Demarco, Maria, Gaglani, Manjusha, Kharbanda, Anupam B, Irving, Stephanie A, Rao, Suchitra, Grannis, Shaun J, Dascomb, Kristin, Murthy, Kempapura, Rowley, Elizabeth A, Dalton, Alexandra F, DeSilva, Malini B, Dixon, Brian E, Natarajan, Karthik, Stenehjem, Edward, Naleway, Allison L, Lewis, Ned, Ong, Toan C, Patel, Palak, Konatham, Deepika, Embi, Peter J, Reese, Sarah E, Han, Jungmi, Grisel, Nancy, Goddard, Kristin, Barron, Michelle A, Dickerson, Monica, Liao, I-Chia, Fadel, William F, Yang, Duck-Hye, Arndorfer, Julie, Fireman, Bruce, Griggs, Eric P, Valvi, Nimish R, Hallowell, Carly, Zerbo, Ousseny, Reynolds, Sue, Ferdinands, Jill, Wondimu, Mehiret H, Williams, Jeremiah, Bozio, Catherine H, Link-Gelles, Ruth, Azziz-Baumgartner, Eduardo, Schrag, Stephanie J, Thompson, Mark G, Verani, Jennifer R
Format: Technical Report
Language:English
Published: 04-03-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:content type line 38
ObjectType-Technical Report-1
SourceType-Reports-1
ISSN:1545-861X
DOI:10.15585/mmwr.mm7109e3